NFKB1 and B-cell chronic lymphocytic leukemia: In this regard, for instance, MSC-derived EVs are able to promote drug resistance in ALL cells by activating NF-κB signaling axis and to protect CLL cells from apoptosis by increasing the expression of anti-apoptotic molecules14,25.